⚠️ High Alert Medication

Amiodarone IV (ACLS & ICU Infusion)

AHA ACLS bolus dosing, syringe pump maintenance infusion (6 mg/mL), and phlebitis and arrhythmia surveillance protocol.

AHA ACLS Quick Reference (Adult)

Cardiac Arrest: Shock-Refractory VF / pVT

Adult Cardiac Arrest Algorithm. Amiodarone or lidocaine may be considered when VF/pVT persists despite defibrillation; the algorithm places the first antiarrhythmic dose after the third shock.

1st dose: 300 mg IV/IO bolus
2nd dose: 150 mg IV/IO bolus
  • Give as a rapid push during CPR, followed by a 20 mL flush; IV access is attempted first, IO if IV is not achievable.
  • Never interrupt chest compressions or delay defibrillation to give amiodarone.
  • Lidocaine alternative: 1–1.5 mg/kg, then 0.5–0.75 mg/kg.

Tachycardia With a Pulse: Stable Wide-QRS

Adult Tachyarrhythmia With a Pulse Algorithm. If the patient is unstable (hypotension, altered mental status, shock, ischemic chest pain, acute heart failure), perform synchronized cardioversion first.

150 mg IV over 10 minutes
  • Repeat 150 mg over 10 minutes if VT recurs.
  • Follow with maintenance infusion: 1 mg/min for 6 hours, then 0.5 mg/min.
  • Procainamide or sotalol are listed alternatives; expert consultation is advised.

Source: 2025 American Heart Association Guidelines for CPR and Emergency Cardiovascular Care, Part 9: Adult Advanced Life Support, and the 2025 ACLS algorithms. Always check local resuscitation policy.

Syringe Pump Maintenance Infusion (Standard Concentration)

Ampoule Presentation 3 mL ampoule (50 mg/mL = 150 mg of amiodarone hydrochloride)
Amiodarone Dose 300 mg (6 mL = two 3 mL ampoules)
Compatible Diluent 44 mL of 5% Dextrose (D5W) only
Final Syringe Volume 50 mL
Final Concentration 6 mg/mL (central line)
Stability 24 hours at room temperature in a polypropylene syringe

Materials Required

  • Amiodarone ampoules 50 mg/mL (3 mL) × 2
  • 60 mL Luer-lock syringe (polypropylene)
  • 5% Dextrose (D5W)
  • Sterile drawing-up needle / filter needle
  • Dedicated syringe pump infusion label
  • Non-PVC (DEHP-free) extension line (100 cm)
  • Alcohol chlorhexidine swabs

Bolus & Loading Dose Preparation

Cardiac Arrest Bolus 300 mg (6 mL) drawn up undiluted, or diluted to 20 mL with D5W, given as rapid IV/IO push. Second dose 150 mg (3 mL) prepared the same way.
Loading Dose (Central Line) 150 mg (3 mL) diluted with D5W to 20 mL (7.5 mg/mL), infused over 10 minutes at 120 mL/hr.
Loading Dose (Peripheral Line) 150 mg (3 mL) in 100 mL D5W (1.5 mg/mL), infused over 10 minutes via a large peripheral vein.

Preparation Procedure (Aseptic Non-Touch Technique)

  1. Verification: Verify the written physician order, patient identity, indication, and baseline heart rate, blood pressure, rhythm, and QTc. During cardiac arrest, follow verbal orders with closed-loop communication.
  2. Hand Hygiene: Perform thorough hand hygiene and clean preparation workspace.
  3. Ampoule Check: Check each amiodarone ampoule for:
    • Correct drug and strength, amiodarone hydrochloride (50 mg/mL)
    • Expiry date
    • Container integrity, clarity, and absence of precipitate
  4. Withdrawal: Open two ampoules of amiodarone. Withdraw 3 mL from each ampoule into a 60 mL Luer-lock syringe (Total amiodarone drawn: 6 mL = 300 mg amiodarone). The solution is viscous; draw up slowly.
  5. Dilution: Add 44 mL of 5% Dextrose to a final volume of 50 mL. Do not dilute with 0.9% Sodium Chloride.
  6. Mixing: Gently invert the syringe several times; avoid vigorous shaking, which causes foaming.
  7. Visual Inspection: Inspect solution to ensure it is clear, pale yellow, and free of visible particles or precipitate.
  8. Labeling & Dual Verification: Apply infusion label and obtain an independent double-check by another registered nurse.
  9. Syringe Pump Setup: Prime a non-PVC extension set and install into the syringe pump.

🔒 Lumen Policy: Amiodarone is incompatible with numerous drugs, including heparin and sodium bicarbonate. Infuse via a dedicated central venous catheter lumen. It leaches plasticizer (DEHP) from PVC, so use non-PVC tubing for infusions lasting longer than 2 hours.

⚠️ Peripheral Administration: Concentrations above 2 mg/mL cause phlebitis and require a central line. If only peripheral access is available, use a large proximal vein and a concentration of 2 mg/mL or less (for example, 900 mg in 500 mL D5W = 1.8 mg/mL).

Electrophysiological Profile

Amiodarone is classified as a Class III antiarrhythmic, but it also has Class I, II, and IV actions. This broad profile explains both its effectiveness and its adverse effects.

Class III (Potassium Channel)

↑ Refractory Period
  • Prolongs repolarization and action potential duration
  • Lengthens the QT interval

Class II & IV (β and Calcium)

↓ Heart Rate & AV Conduction
  • Slows sinus rate and AV nodal conduction
  • Useful for ventricular rate control in atrial fibrillation

IV Formulation Effect

Vasodilation & Hypotension
  • Hypotension is the most common acute adverse effect of IV dosing
  • Related to infusion rate; slow the infusion if it occurs

Administration & 24-Hour Infusion Regimen

Recommended Dosing Parameters (Patient With a Pulse)

  • Rapid Loading: 150 mg over 10 minutes (15 mg/min).
  • Rapid Maintenance: 1 mg/min for 6 hours (360 mg) = 10 mL/hr of the 6 mg/mL syringe.
  • Slow Maintenance: 0.5 mg/min for 18 hours (540 mg) = 5 mL/hr.
  • Breakthrough VT/VF: Supplemental 150 mg over 10 minutes may be repeated.
  • Maximum Dose: 2.2 g in 24 hours (all IV doses combined).
  • After Cardiac Arrest: Following ROSC, a maintenance infusion may be started on clinician order using the same regimen.
  • Beyond 24 Hours: Continue 0.5 mg/min or convert to oral therapy as directed.
  • Syringe Continuity: At 10 mL/hr a 50 mL syringe lasts 5 hours. Prepare the next syringe in time; it may be made up a maximum of 1 hour in advance and labelled clearly with contents and expiry.
  • Discard Policy: Discard 24 hours after preparation or earlier if the solution becomes cloudy, precipitated, or contaminated.

Monitoring Requirements

  • Continuous ECG monitoring for bradycardia, AV block, and QTc prolongation; record QTc at baseline and regularly during infusion.
  • Monitor blood pressure frequently during loading (arterial line preferred in the ICU).
  • Keep serum potassium and magnesium in the normal range.
  • Check liver function and thyroid function at baseline and during continued therapy.
  • Inspect the infusion site regularly for phlebitis (pain, erythema, induration).

Contraindications & Cautions

  • Contraindicated (non-arrest settings): Cardiogenic shock, marked sinus bradycardia, and second- or third-degree AV block without a functioning pacemaker.
  • QT-Prolonging Drugs: Additive risk of torsades de pointes; review all concurrent medications.
  • Interactions: Raises digoxin and warfarin effect; dose reduction and closer monitoring are usually needed.
  • Hypersensitivity: Known allergy to amiodarone or iodine.

Phlebitis & Extravasation Response Protocol

Amiodarone is an irritant; concentrated solutions cause phlebitis, and extravasation can lead to skin necrosis.

Normal Infusion Site

  • No erythema or streaking along the vein
  • No local swelling or induration
  • No pain, burning, or stinging
  • No tissue discolouration

Phlebitis or Extravasation Suspected:

  1. STOP infusion immediately (do not flush line).
  2. Notify clinician promptly and arrange alternative (preferably central) access.
  3. Aspirate residual drug through the cannula if possible, then remove catheter.
  4. Elevate the limb and manage per local extravasation policy.
  5. Document event in patient clinical record.

Amiodarone Infusion Rate Chart (6 mg/mL)

Amiodarone infusions are dosed in mg/min, independent of weight. Shows the pump rate for each dose and the amount delivered per hour and per 24 hours.

Dose
(mg/min)
Pump Rate
(mL/hr)
Delivered
(mg/hr)
If Continued 24 hr
(mg)
Standard Regimen Phase
0.252.515360—
0.5530720Slow maintenance (hours 7–24)
0.757.5451080—
110601440Rapid maintenance (hours 1–6)

First 24 Hours: Standard Regimen Summary

Phase Dose Duration Drug Delivered Rate
Rapid loading150 mg10 min150 mg120 mL/hr (20 mL syringe)
Rapid maintenance1 mg/min6 hr360 mg10 mL/hr (6 mg/mL)
Slow maintenance0.5 mg/min18 hr540 mg5 mL/hr (6 mg/mL)
Total24 hours1,050 mgMaximum 2.2 g / 24 hr including boluses

Infusion Conversion (Solution Concentration 6 mg/mL)

Standard equations for a 6 mg/mL solution (300 mg in 50 mL):

Infusion Rate (mL/hr):

Rate (mL/hr) = [ Dose (mg/min) × 60 ] / 6

Shortcut: Rate = Dose × 10
Infusion Dose (milligrams/minute):

Dose (mg/min) = [ Rate (mL/hour) × Concentration (6 mg/mL) ] / 60

Shortcut: Dose = Rate ÷ 10

Worked example: 1 mg/min → 1 × 10 = 10 mL/hr; 0.5 mg/min → 5 mL/hr.

© criticalcareinsights.com. All rights reserved. For clinical reference and educational use only.